Taken together, our findings support further interrogation of the intrinsic apoptosis pathway to assist with the development of therapeutic strategies targeting anti-apoptotic BCL2 family proteins, to deliver cancer specific kill for men suffering from lethal PCa. This evidence concerns the gene BCL2 and cancer.